Centessa Pharmaceuticals plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | 04/21/2026 | 19.96 M | $792.94 M | 0.00% | 13.00% |
| AVORO CAPITAL ADVISORS LLC | 05/15/2026 | 11.43 M | $454.02 M | -21.47% | 7.44% |
| INDEX VENTURE LIFE ASSOCIATES VI LTD | 05/15/2026 | 9.96 M | $395.68 M | 0.00% | 6.49% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2026 | 8.93 M | $354.50 M | -20.89% | 5.81% |
| PENTWATER CAPITAL MANAGEMENT LP | 05/15/2026 | 8.17 M | $324.51 M | 100.00% | 5.32% |
| FMR LLC | 05/15/2026 | 6.85 M | $272.16 M | -23.54% | 4.46% |
| ECOR1 CAPITAL, LLC | 05/15/2026 | 6.00 M | $238.32 M | 92.62% | 3.91% |
| PERCEPTIVE ADVISORS LLC | 05/29/2026 | 5.26 M | $208.88 M | 80.25% | 3.42% |
| CAPITAL WORLD INVESTORS | 05/13/2026 | 4.83 M | $191.95 M | 317.07% | 3.15% |
| FARALLON CAPITAL MANAGEMENT LLC | 05/15/2026 | 4.81 M | $191.01 M | -10.56% | 3.13% |
| TCG CROSSOVER MANAGEMENT, LLC | 05/15/2026 | 4.29 M | $170.26 M | 0.00% | 2.79% |
| MORGAN STANLEY | 05/15/2026 | 4.27 M | $169.54 M | 284.85% | 2.78% |
| PARADIGM BIOCAPITAL ADVISORS LP | 05/15/2026 | 3.57 M | $141.96 M | 100.00% | 2.33% |
| JANUS HENDERSON GROUP PLC | 05/18/2026 | 3.49 M | $138.74 M | -14.67% | 2.27% |
| DEEP TRACK CAPITAL, LP | 05/15/2026 | 3.16 M | $125.44 M | 57.90% | 2.06% |
| LOGOS GLOBAL MANAGEMENT LP | 05/15/2026 | 2.13 M | $84.41 M | 962.50% | 1.38% |
| RTW INVESTMENTS, LP | 05/15/2026 | 2.05 M | $81.59 M | 14.70% | 1.34% |
| FEDERATED HERMES, INC. | 05/11/2026 | 2.05 M | $81.40 M | -12.50% | 1.33% |
| BRAIDWELL LP | 05/15/2026 | 1.99 M | $78.91 M | -9.21% | 1.29% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 1.93 M | $76.76 M | 103.51% | 1.26% |
| MAVERICK CAPITAL LTD | 05/15/2026 | 1.85 M | $73.66 M | 12.82% | 1.21% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 05/15/2026 | 1.56 M | $62.00 M | -31.50% | 1.02% |
| AFFINITY ASSET ADVISORS, LLC | 05/14/2026 | 1.40 M | $55.61 M | 133.12% | 0.91% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 05/15/2026 | 1.36 M | $54.18 M | 0.00% | 0.89% |
| GENERAL ATLANTIC, L.P. | 05/15/2026 | 1.35 M | $53.81 M | -77.85% | 0.88% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 1.14 M | $45.46 M | 46.93% | 0.75% |
| SIREN, L.L.C. | 05/14/2026 | 1.05 M | $41.84 M | -73.84% | 0.69% |
| CORMORANT ASSET MANAGEMENT, LP | 05/15/2026 | 1.05 M | $41.71 M | -20.75% | 0.68% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 04/21/2026 | 865.50 K | $34.38 M | 100.00% | 0.56% |
| WOODLINE PARTNERS LP | 05/15/2026 | 859.11 K | $34.12 M | 48.57% | 0.56% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 852.83 K | $33.87 M | 81.91% | 0.56% |
| OCTAGON CAPITAL ADVISORS LP | 05/15/2026 | 750.00 K | $29.79 M | 0.00% | 0.49% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 722.12 K | $28.68 M | -61.40% | 0.47% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 05/14/2026 | 702.25 K | $27.89 M | 100.00% | 0.46% |
| AMERICAN CENTURY COMPANIES INC | 05/15/2026 | 687.43 K | $27.30 M | -39.15% | 0.45% |
| FRANKLIN RESOURCES INC | 05/13/2026 | 684.48 K | $27.19 M | -71.10% | 0.45% |
| BAKER BROS. ADVISORS LP | 05/15/2026 | 670.75 K | $26.64 M | 0.00% | 0.44% |
| EVENTIDE ASSET MANAGEMENT, LLC | 05/15/2026 | 668.14 K | $26.54 M | 100.00% | 0.44% |
| TORONTO DOMINION BANK | 05/15/2026 | 654.85 K | $26.01 M | 100.00% | 0.43% |
| TIG ADVISORS, LLC | 05/15/2026 | 648.33 K | $25.75 M | 100.00% | 0.42% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 643.81 K | $25.57 M | -22.59% | 0.42% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 05/15/2026 | 635.00 K | $25.22 M | 100.00% | 0.41% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 628.05 K | $24.95 M | 65.83% | 0.41% |
| BLACKROCK, INC. | 05/13/2026 | 625.42 K | $24.84 M | 5.54% | 0.41% |
| CITADEL ADVISORS LLC | 05/15/2026 | 598.20 K | $23.76 M | 15.05% | 0.39% |
| 5AM VENTURE MANAGEMENT, LLC | 05/15/2026 | 580.95 K | $23.08 M | 0.00% | 0.38% |
| PFM HEALTH SCIENCES, LP | 05/15/2026 | 528.22 K | $20.98 M | -10.71% | 0.34% |
| WEISS ASSET MANAGEMENT LP | 05/15/2026 | 510.41 K | $20.27 M | 100.00% | 0.33% |
| SPRUCE STREET CAPITAL LP | 05/14/2026 | 489.85 K | $19.46 M | 528.04% | 0.32% |
| JPMORGAN CHASE & CO | 05/13/2026 | 477.60 K | $13.17 M | 486.11% | 0.31% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Centessa Pharmaceuticals plc institutional Ownership - FAQ's
During the previous two years, 169 institutional investors and hedge funds held shares of Centessa Pharmaceuticals plc. The most heavily invested institutionals were:
BNP Paribas Asset Management Holding S.A.: 0
FMR LLC: 0
PERCEPTIVE ADVISORS LLC: 0
SILVERARC CAPITAL MANAGEMENT, LLC: 0
J.Safra Asset Management Corp: 0
MARSHALL WACE, LLP: 0
109.52% of Centessa Pharmaceuticals plc stock is owned by institutional investors.
Institutional investors have bought a total of 17.45 M shares in the last 24 months. This purchase volume represents approximately $455.16 M in transactions.